VRTX logo

VRTX
Vertex Pharmaceuticals, Inc.

12,732
Mkt Cap
$113.44B
Volume
1.19M
52W High
$510.77
52W Low
$362.50
PE Ratio
29.17
VRTX Fundamentals
Price
$447.26
Prev Close
$446.54
Open
$449.17
50D MA
$468.34
Beta
0.57
Avg. Volume
1.49M
EPS (Annual)
$15.32
P/B
6.09
Rev/Employee
$1.89M
$112,391.78
Loading...
Loading...
News
all
press releases
Vertex Announces US FDA Approval for Label Extensions of ALYFTREK and TRIKAFTA, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK (vanzacaftor/tezacaftor/ivacaftor) for the...
Business Wire·14h ago
News Placeholder
More News
News Placeholder
Promising Biotech Stocks To Watch Now - March 31st
Danaher, United Therapeutics, Vertex Pharmaceuticals, argenex, and Moderna are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop, and commercialize biological products, therapies, diagnostics, and rel...
MarketBeat·1d ago
News Placeholder
If You Invested $1000 In Vertex Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today
read more...
Benzinga·2d ago
News Placeholder
Biotech Stocks To Watch Today - March 30th
United Therapeutics, Danaher, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop, and commercialize biological products and technologiessuch as drugs, vaccines, diagnos...
MarketBeat·2d ago
News Placeholder
Best Biotech Stocks To Watch Today - March 29th
Danaher, Vertex Pharmaceuticals, and Moderna are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies focused on developing and commercializing biological products, such as drugs, gene therapies, vaccines, and diagnostic tech...
MarketBeat·3d ago
News Placeholder
Biotech Stocks To Keep An Eye On - March 28th
Danaher, Vertex Pharmaceuticals, and Moderna are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are publicly traded shares of companies that develop biological products and technologiessuch as drugs, vaccines, diagnostics, and gene or cell th...
MarketBeat·4d ago
News Placeholder
Promising Biotech Stocks To Add to Your Watchlist - March 27th
Danaher, Onconetix, Moderna, argenex, Vertex Pharmaceuticals, Abivax, and Rocket Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·5d ago
News Placeholder
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Congress Asset Management Co.
Congress Asset Management Co. trimmed its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 99.4% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 937 shares of the pharmaceutical company's stock after selling 159,938 shares du...
MarketBeat·6d ago
News Placeholder
Baker Chad R Sells 8,990 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Baker Chad R reduced its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 92.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 750 shares of the pharmaceutical company's stock after selli...
MarketBeat·6d ago
News Placeholder
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Consensus Rating of "Moderate Buy" by Analysts
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twenty-nine brokerages that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating, twenty-three...
MarketBeat·6d ago
<
1
2
...
>

Latest VRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.